CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
105 hedge funds and large institutions have $305M invested in Carisma Therapeutics in 2021 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
36% more call options, than puts
Call options by funds: $6.74M | Put options by funds: $4.96M
0.73% more ownership
Funds ownership: 1.18% → 1.91% (+0.73%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
105
Holding in Top 10
1
Calls
$6.74M
Puts
$4.96M
Top Buyers
| 1 | +$62.6M | |
| 2 | +$35.7M | |
| 3 | +$7.15M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$6.41M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.04M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$3.41M | |
| 3 | -$1.72M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.33M |
| 5 |
VF
Virtu Financial
New York
|
-$1.08M |